Clinical Trials Directory

Trials / Recruiting

RecruitingNCT04130789

Personalized Swiss Sepsis Study

Personalized Swiss Sepsis Study: With Machine Learning and Computational Modelling Towards Personalized Sepsis Management - Discovery of Digital Biomarkers

Status
Recruiting
Phase
Study type
Observational
Enrollment
17,500 (estimated)
Sponsor
University Hospital, Basel, Switzerland · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This multi-center study is to focus on patients with sepsis in Intensive Care Units (ICUs) in order to better understand the complex host-pathogen interaction and clinical heterogeneity associated with sepsis. Understanding this heterogeneity may allow the development of novel diagnostic approaches. Data from patients will be analyzed using state-of-the art analytical algorithms for biomarker discovery including machine learning and multidimensional mathematical modelling to explore the large datasets generated. In order to discover digital biomarkers for the study endpoints a case-control study design will be used to compare data patterns from patients with sepsis (cases) and those without sepsis (controls).

Conditions

Interventions

TypeNameDescription
OTHERcompare data patterns by data-driven algorithms to determine sepsiscompare data patterns by data-driven algorithms including machine learning and multi-dimensional modelling to reliably determine sepsis
OTHERcompare data patterns by data-driven algorithms to predict sepsis-related mortalitycompare data patterns by data-driven algorithms including machine learning and multi-dimensional modelling to to predict sepsis-related mortality

Timeline

Start date
2019-11-15
Primary completion
2022-05-31
Completion
2025-12-01
First posted
2019-10-17
Last updated
2025-03-05

Locations

16 sites across 1 country: Switzerland

Source: ClinicalTrials.gov record NCT04130789. Inclusion in this directory is not an endorsement.